Navigation Links
UCSF study finds clinic-based HIV prevention is effective in reducing risk behaviors
Date:3/24/2010

UCSF researchers have shown that delivering HIV prevention services to people living with HIV in clinical settings can sharply reduce their sexual risk behaviors.

The findings are available now in the online edition of the journal "AIDS and Behavior" and are scheduled for publication in an upcoming print issue.

"We found the greatest and most sustained reductions in sexual risk took place when the prevention interventions were delivered by medical care providers during HIV patients' routine visits. An important feature of this research is that it was conducted in actual clinical settings and not in the somewhat artificial setting of a clinical trial," said the study's lead author, Janet J. Myers, PhD, MPH, assistant professor of medicine at the UCSF Center for AIDS Prevention Studies and co-principal investigator of the project.

When they received risk assessment prevention counseling from their clinical providers, HIV patients showed a consistent decline in risky behavior over the 12-month study period. The researchers saw HIV patients cut almost in half their sexual risk behaviors: unprotected anal or vaginal intercourse with either a HIV-negative partner or one whose status was unknown. HIV patients receiving services from health educators, social workers or peer educators also significantly reduced risk behaviors at 6 months, but not at 12 months.

"Other studies testing behavioral prevention interventions have demonstrated that boosters delivered at periodic intervals assist in sustaining behavior changes. Since patients see their medical providers regularly to monitor disease and therapeutic regimens, delivering prevention services during these visits is not only exceedingly effective in reducing risk behaviors, but is likely to be highly cost-effective," said Steve Morin, PhD, professor of medicine and director of the UCSF Center for AIDS Prevention Studies and the study's principal investigator.

The roughly 3500 HIV-positive trial participants were diversehalf of the sample was men who have sex with men, 30 percent was women and 20 percent was heterosexual men. The research was conducted at 13 demonstration sites in 12 states and included sites in major urban centers and sites in smaller cities.

"These findings are very robust given the number of participants and their diversity and the variety of sites where the research was conducted. This intervention, especially when delivered by medical care providers, should be considered for inclusion in emerging 'test and treat' and 'test, treat and link to care' models that seek to dramatically increase the number of HIV-infected patients receiving care. The expected prevention benefits from increasing the number of people who know their HIV status and from successfully achieving some viral control amongst those infected could be effectively and efficiently increased if these behavioral interventions are included as part of a combination HIV prevention effort," said Morin.


'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. Casual Sex Doesnt Cause Emotional Damage: Study
2. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
3. Screening for Spinal Muscular Atrophy Not Cost-Effective: Study
4. New study finds possible source of beta cell destruction that leads to Type 1 diabetes
5. New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
6. Risk of stroke lower for recent Ontario immigrants: study
7. Definitive study confirms chemo benefit in postmenopausal breast cancer
8. Experimental stem cell treatment arrests acute lung injury in mice, study shows
9. Violence is part of the job say nurses as study shows only 1 in 6 incidents are reported
10. Controversial Autism Study Retracted by Medical Journal
11. Study Reveals Impact Of Health Insurance On Hispanics' Attitudes Towards Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology: